Form 4: Medpace Holdings President Jesse J. Geiger Reports Stock Option Grant

Jesse J. Geiger, President of Medpace Holdings, reports the acquisition of stock options.

Summary

• On March 6, 2025, Jesse J. Geiger, President of Medpace Holdings, Inc., reported a transaction involving derivative securities.
• Geiger acquired 9,886 employee stock options with an exercise price of $325.73.
• These options vest on March 6, 2030, contingent upon continued employment with Medpace or its subsidiaries.
• Geiger also directly owns 36,503 shares of Medpace Holdings common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports a transaction.

Positives

• The grant of stock options to a key executive like the President can be seen as an incentive to align their interests with those of the shareholders.
• Continued employment is required for the options to vest, which may encourage the executive to remain with the company.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The stock option grant could potentially impact shareholders by diluting equity if the options are exercised in the future.
• The grant incentivizes the President, which could benefit the company and its stakeholders.

Key Dates